Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients Diagnosed With Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT02364050
What this trial is testing

Prospective Data Collection of Elderly Patients With DLBCL Receiving at the Time of Diagnosis VGM

Who this might be right for
Lymphoma, Large B-Cell, Diffuse
Fondazione Italiana Linfomi - ETS 1,300
Not applicableStudy completedNCT04745416
What this trial is testing

Clinical Characteristics of Patients With Leukemia and COVID-19

Who this might be right for
Leukemia, AcuteCovid19Leukemia, Lymphoblastic
Hospital General de Mexico 30
Not applicableUnknownNCT03033485
What this trial is testing

18F-Labeled Picolinamide PET Imaging of Melanoma Diagnosis

Who this might be right for
Melanoma
Xijing Hospital 50
Testing effectiveness (Phase 2)Ended earlyNCT03897491
What this trial is testing

PD L 506 for Stereotactic Interstitial Photodynamic Therapy of Newly Diagnosed Supratentorial IDH Wild-type Glioblastoma

Who this might be right for
Glioblastoma
photonamic GmbH & Co. KG 17
Not applicableLooking for participantsNCT07768124
What this trial is testing

Acupoint Application for Chemotherapy-Induced Nausea and Vomiting in Lung Cancer

Who this might be right for
Lung Cancer (Diagnosis)Chemotherapy-Induced Nausea and Vomiting
Xiu Huang 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT04052880
What this trial is testing

Study of SubQ Dara With Dose-Attenuated Bortezomib, Lenalidomide, Dexamethasone in Elderly NDMM

Who this might be right for
Newly Diagnosed Multiple Myeloma
Larysa Sanchez 17
Not applicableActive Not RecruitingNCT02185560
What this trial is testing

Prospective, Non-interventional, Post-authorization Safety Study That Includes All Patients Diagnosed as Unresectable Differentiated Thyroid Carcinoma and Treated With Sorafenib

Who this might be right for
Thyroid Carcinoma
Bayer 453
Testing effectiveness (Phase 2)WithdrawnNCT05664893
What this trial is testing

Study to Determine the Safety and Efficacy of Ribociclib in Combination With Hormone Therapy and Hypofractionated Radiotherapy in Breast Cancer, With Positive Hormone Receptors and Negative HER2 Status, in Newly Diagnosed, Not Immediately Operable Elderly Patient (CALHYS)

Who this might be right for
HER2 Negative Breast Cancer Not Immediately Operated
Centre Antoine Lacassagne
Testing effectiveness (Phase 2)Looking for participantsNCT05713006
What this trial is testing

Alectinib Pharmacokinetic in Patients With NSCLC

Who this might be right for
Non-small Cell Lung Cancer Stage IIIBALK Gene Mutation
Instituto Nacional de Cancerologia de Mexico 45
Very early researchStudy completedNCT01165632
What this trial is testing

Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed High- or Low-Grade Malignant Glioma

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+13 more
Mayo Clinic 24
Not applicableStudy completedNCT00364624
What this trial is testing

Adrenal Function in Patients With Newly Diagnosed Lung Cancer

Who this might be right for
Lung CancerAdrenal Insufficiency
Princess Margaret Hospital, Hong Kong 133
Large-scale testing (Phase 3)Study completedNCT00017147
What this trial is testing

S0001 RT and Carmustine With or Without O6BG in Patients With New Glioblastoma Multiforme or Gliosarcoma

Who this might be right for
Malignant Neoplasms of Eye, Brain and Other Parts of Central Nervous System
SWOG Cancer Research Network 183
Testing effectiveness (Phase 2)Active Not RecruitingNCT02923778
What this trial is testing

Talimogene Laherparepvec and Radiation Therapy in Treating Patients With Newly Diagnosed Soft Tissue Sarcoma That Can Be Removed by Surgery

Who this might be right for
LeiomyosarcomaLiposarcomaSarcoma G2+6 more
National Cancer Institute (NCI) 40
Large-scale testing (Phase 3)Study completedNCT00471497
What this trial is testing

Imatinib Versus Nilotinib in Adult Patients With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)

Who this might be right for
Myelogenous Leukemia, Chronic
Novartis Pharmaceuticals 846
Not applicableLooking for participantsNCT07510724
What this trial is testing

Real-World Data on the Treatment of Lung Cancer Patients With the Immune-Checkpoint Inhibitor Tislelizumab

Who this might be right for
Small Cell Lung Cancer (SCLC)Non-Small Cell Lung Cancer (NSCLC)Lung Cancer (Diagnosis)
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 240
Large-scale testing (Phase 3)Study completedNCT00703820
What this trial is testing

Clofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Study Of NK Cell Transplantation In Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
St. Jude Children's Research Hospital 324
Testing effectiveness (Phase 2)Study completedNCT01481194
What this trial is testing

ACVDL Treatment for Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Vejle Hospital 35
Not applicableUnknownNCT02934360
What this trial is testing

TR(ACE) Assay Clinical Specimen Study

Who this might be right for
Carcinoma, Non-Small-Cell LungBreast Neoplasms
Biological Dynamics 450
Not applicableEnded earlyNCT00891969
What this trial is testing

Treatment Decision Making Between Oncologists and Women With Newly Diagnosed Breast Cancer and Their Healthy Companions

Who this might be right for
Breast Cancer
Rutgers, The State University of New Jersey 77
Large-scale testing (Phase 3)UnknownNCT00954174
What this trial is testing

Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer

Who this might be right for
Mixed Mesodermal (Mullerian) TumorOvarian CarcinosarcomaRecurrent Fallopian Tube Carcinoma+39 more
GOG Foundation 637
Next Page